SABCS San Antonio Breast Cancer Symposium 2026
The San Antonio Breast Cancer Symposium is a four-day scientific meeting on breast cancer research and care, held every December. It draws oncologists, researchers, and pharma and diagnostics companies.
Tuesday to Friday · 4 days
Henry B. González Convention Center
UT Health San Antonio / AACR
Organizer · held every year
Published by the organizer
Registration platform
Checked November 10, 2026
Reported attendance
11,626
attendees · 2025
Reported exhibitors
125+ exhibitors · 2026
About SABCS San Antonio Breast Cancer Symposium 2026
The San Antonio Breast Cancer Symposium (SABCS) is the yearly scientific meeting on breast cancer research and care. UT Health San Antonio and the American Association for Cancer Research present it together. The 2026 symposium runs December 8 to 11 at the Henry B. González Convention Center in San Antonio, Texas. It's built for oncologists, researchers, patient advocates and the drug and diagnostics companies that serve them. The organizer's prospectus counts 11,626 in-person and virtual attendees in 2025.
129
Exhibitors on the official list
104
Countries represented
73
Sessions in the program
$39.6 million
Economic impact (Visit San Antonio)
2,300+
Abstracts
What happens at SABCS
SABCS is four days of scientific sessions, posters and an exhibit hall on breast cancer. The overview page says the program mixes expert lectures, oral and poster presentations, forums and case discussions.
The 2026 online program lists 73 sessions. It runs from workshops and special sessions on Tuesday, December 8, to general sessions with late-breaking data later in the week. The 2025 program listed 84 sessions.
Seven special sessions cover topics such as lifestyle medicine, prevention vaccines, weight-loss drugs, AI and lobular cancer, per SABCS Meeting News. A special session on lobular breast cancer runs late on December 9. Two new hands-on workshops on Tuesday need a small fee and advance booking, the organizer says.
Satellite Educational Symposia are independent CME programs held each evening at the San Antonio Marriott Rivercenter. SABCS says they aren't official parts of its program. Companies can also host approved affiliate meetings at affiliate hotels from December 7 to 10.
English is the only language, and there's no simultaneous translation, per the organizer. All registrants can stream sessions and watch recordings on demand.
What's new for SABCS 2026
SABCS added four special sessions in 2026, for seven in total, per SABCS Meeting News. New topics include weight-loss drugs, AI-driven drug development and the drivers of disparities.
New hands-on workshops cover alternatives to animal models and AI in pathology, the organizer says. The exhibit hall adds an AI maker space where attendees can try AI platforms.
Other events teams in oncology also follow the AACR Annual Meeting 2027 and the ASCO Annual Meeting 2027.
Who attends SABCS
The audience is mostly clinicians and researchers, with a large industry share. The 2026 exhibitor prospectus counts 11,626 in-person and virtual attendees in 2025, up from 11,068 in 2024 and 10,867 in 2023.
- 202511,626
- 202411,068
- 202310,867
2025 · sabcs.org ↗
- Medical Practice/Clinical Research53.46%
- Industry26.49%
- Basic and Translational Research8.96%
- Other (Patient Advocate, PR, Pharmacist, Student)5.95%
From the 2026 exhibitor prospectus. The year isn't given.sabcs.org ↗
- Clinical Practice23.72%
- Medical Practice20.4%
- Clinical Research19.38%
- Advocacy8.56%
- Translational Research5.86%
- Basic Research5.55%
- Business Development4.79%
- Population Science3.65%
- Prevention2.42%
From the 2026 exhibitor prospectus. The year isn't given.sabcs.org ↗
- United States63.7%
- Brazil2.73%
- United Kingdom2.53%
- Spain2.31%
- Japan2.07%
- Italy2.01%
- Germany2%
- Canada1.78%
- China1.72%
- Mexico1.54%
From the 2026 exhibitor prospectus. The year isn't given.sabcs.org ↗
By occupation, the prospectus puts medical practice and clinical research at 53.46%. Industry makes up 26.49%, and basic and translational research 8.96%. It doesn't say which year these shares cover.
By professional focus, clinical practice leads at 23.72%, then medical practice at 20.40% and clinical research at 19.38%. Advocacy accounts for 8.56% and business development for 4.79%.
The United States supplies 63.70% of attendees in the same chart. Brazil, the United Kingdom, Spain and Japan follow, each with about 2% to 3%.
UT Health San Antonio says attendees came from 104 countries in 2025. It cites a Visit San Antonio report putting the economic impact at $39.6 million. Trade outlet AJMC described the 2024 meeting as drawing over 11,000 attendees from more than 100 countries.
Attendance and exhibitors by year
As the organizer reports them. What's counted varies between events, so compare with care.
| Edition | Attendance | Exhibitors |
|---|---|---|
| 2026 | Not published | 125+ exhibitorssabcsmeetingnews.org ↗ |
| 2025 | 11,626in-person and virtual attendeessabcs.org ↗ | Not published |
| 2024 | 11,068in-person and virtual attendeessabcs.org ↗ | Not published |
| 2023 | 10,867in-person and virtual attendeessabcs.org ↗ | Not published |
Companies exhibiting and sponsoring at SABCS 2026
Drugmakers, diagnostics firms, imaging companies and patient groups fill the exhibit hall. The official 2026 exhibitor list showed 129 exhibitors when we checked on 10 November 2026, up from 125 on 24 October.
Sponsors (5)AstraZeneca, Pfizer Oncology, Daiichi Sankyo and 2 more
- AstraZeneca · 2026drugmaker, 2026 exhibitor at booth 624, sponsor of the Headshot Lounge and Wellness Lounge and product theater supporter
- Pfizer Oncology · 2026listed as a 2026 exhibitor, and Pfizer supports the Patient Advocacy Pavilion
- Daiichi Sankyo · 20262026 exhibitor at booth 343 and a product theater supporter
- Aflacsupports the AACR Distinguished Lectureship in Breast Cancer Research
- Breast Cancer Research Foundationsupports the AACR Outstanding Investigator Award for Breast Cancer Research
Partners (5)Research To Practice, PeerView Institute for Medical Education, Clinical Care Options and 2 more
- Research To Practice · 2026hosts a 2026 Satellite Educational Symposium
- PeerView Institute for Medical Education · 2026hosts a 2026 Satellite Educational Symposium
- Clinical Care Options · 2026hosts a 2026 Satellite Educational Symposium
- Physicians' Education Resource · 2026hosts a 2026 Satellite Educational Symposium
- Answers in CME · 2026hosts a 2026 Satellite Educational Symposium
Exhibitors (37)Eli Lilly and Company, Genentech, Novartis Pharmaceuticals Corporation and 34 more
- Eli Lilly and Company · 2026listed as a 2026 exhibitor
- Genentech · 2026listed as a 2026 exhibitor
- Novartis Pharmaceuticals Corporation · 2026listed as a 2026 exhibitor
- Merck & Co., Inc. · 2026listed as a 2026 exhibitor
- Bristol Myers Squibb · 2026listed as a 2026 exhibitor
- Gilead Sciences · 2026listed as a 2026 exhibitor
- Boehringer Ingelheim International GmbH · 2026listed as a 2026 exhibitor
- BioNTech · 2026listed as a 2026 exhibitor
- BeOne Medicines USA · 2026listed as a 2026 exhibitor
- Jazz Pharmaceuticals · 2026listed as a 2026 exhibitor
- Puma Biotechnology · 2026listed as a 2026 exhibitor
- Relay Therapeutics · 2026listed as a 2026 exhibitor
- Olema Oncology · 2026listed as a 2026 exhibitor
- 10x Genomics · 2026life science tools, listed at booth 1433 for 2026
- Agendia · 2026precision oncology testing, listed at booth 1242 for 2026
- Caris Life Sciences · 2026listed as a 2026 exhibitor
- Foundation Medicine · 2026listed as a 2026 exhibitor
- Guardant Health · 2026listed as a 2026 exhibitor
- Natera · 2026listed as a 2026 exhibitor
- Myriad Genetics · 2026listed as a 2026 exhibitor
- Tempus · 2026listed as a 2026 exhibitor
- Veracyte · 20262026 exhibitor at booth 1424, showing the Prosigna test
- Quest Diagnostics · 2026listed as a 2026 exhibitor
- Hologic · 2026breast imaging, listed as a 2026 exhibitor
- GE Healthcare · 2026listed as a 2026 exhibitor
- Ataraxis · 2026listed as a 2026 exhibitor, with tools in the new AI maker space
- Lantern Pharma · 2026listed as a 2026 exhibitor, with tools in the new AI maker space
- Susan G. Komen · 2026breast cancer nonprofit, listed as a 2026 exhibitor
- American Society of Clinical Oncology (ASCO) · 2026listed as a 2026 exhibitor
- Rigel · 20262026 exhibitor with a product theater on vedepgestrant
- Bio-Rad Laboratories · 20262026 exhibitor with a product theater on ESR1 testing by ddPCR
- Exact Sciences (now Abbott) · 20262026 exhibitor with a product theater on MRD and ctDNA
- Organon · 2026listed as a 2026 exhibitor
- Menarini-Stemline · 2026listed as a 2026 exhibitor
- BostonGene · 2026listed as a 2026 exhibitor
- NeoGenomics · 2026listed as a 2026 exhibitor
- Celcuity · 2026listed as a 2026 exhibitor
Big oncology drugmakers include AstraZeneca, Pfizer Oncology, Daiichi Sankyo, Eli Lilly, Genentech and Novartis. Testing firms such as Caris, Foundation Medicine, Guardant Health and Natera are also listed. Newer names on the list include Rigel, Organon, Menarini-Stemline and Bio-Rad Laboratories.
Many nonprofits exhibit too. SABCS Meeting News says the Patient Advocacy Pavilion hosts more than two dozen advocacy groups.
Research centers and institutions also send teams. Emory's Winship Cancer Institute said its specialists would take part in 22 presentations at SABCS 2025.
Exhibitors at SABCS and how to exhibit
Exhibitors book space through the organizer's exhibition page, which links to the application and live floor plan. The 2026 hall runs on Map Your Show.
Inline booths cost $80 per square foot and premium or island booths $106, per the organizer. Nonprofits pay $40 inline or $53 for a corner, and patient advocacy groups can apply for a free kiosk.
Each booth includes two exhibit-hall badges per 100 square feet, the prospectus says. Exhibitor meeting rooms in Hall 4 cost $10,000 for 10 by 20 feet, up to $30,000 for 30 by 20 feet.
The hall opens at noon on December 9, 10 and 11. It closes in the early evening on the first two days and at 3 p.m. on Friday. Posters, product theaters and a new AI maker space with Ataraxis AI and Lantern Pharma sit in the same hall.
Final payment for 2026 space was due August 14, and no refunds apply after mid August. Freeman is the general contractor, and CMR handles registration and lead retrieval.
Sponsors and supporters at SABCS
SABCS sells sponsorships to exhibitors through a 2026 support prospectus. The exhibitor prospectus mentions column wraps, digital signage, product theaters and mobile charging.
Pfizer supports the Patient Advocacy Pavilion, and AstraZeneca sponsors the Headshot Lounge and Wellness Lounge, SABCS Meeting News reports. The industry events listing shows product theaters supported by Pfizer, and by Daiichi Sankyo with AstraZeneca.
The organizer's 2026 product theater schedule lists 12 industry talks in two Hall 3 theaters on December 9 and 10. Companies include Pfizer, Daiichi Sankyo, AstraZeneca, Merck, Eli Lilly, Novartis, GE Healthcare, Hologic, Rigel, Bio-Rad and Exact Sciences.
Airport, hotel and outdoor branding goes through TriStar Event Media, per the exhibition page. The awards page says Aflac supports the AACR Distinguished Lectureship and the Breast Cancer Research Foundation supports the Outstanding Investigator Award.
Teams planning similar programs can compare event sponsorship software.
The event's tech
Registration runs on Cadmium (Eventscribe), based on the registration links on the event's website (checked October 18, 2026).
SABCS attendee list, exhibitor list and sponsor list
Exhibitor list
Published
Sponsor list
Not published
Attendee list
Not published or sold
The official exhibitor list is public on the SABCS 2026 Map Your Show directory, with a linked interactive floor plan. There's no separate public sponsor list.
SABCS doesn't share, sell, rent or distribute its attendee lists, the exhibitor prospectus says. It warns that companies offering mailing lists aren't authorized and have no access to them.
Instead, exhibitors can rent lead retrieval from CMR. They can also buy email blasts sent to pre- and post-meeting registrants through CMR, per the prospectus.
The registration page also warns attendees about fraudulent registration and housing websites. For other ways to research who'll be at an event, see how to find who's attending an event and event intelligence platforms.
See who's attending SABCS San Antonio Breast Cancer Symposium
Organizers don't publish attendee lists. These event intelligence platforms show which companies and roles are likely to attend and help you book meetings. How to find who's attending
Speakers at SABCS 2026
SABCS has published its 2026 speakers in its online program. Futurist Jamie Metzl gives the keynote address on December 9 at 9 a.m. in Hall 1, on AI, genetics and biotechnology.
More speakers (56)Charles M. Perou, Fabrice André, Virginia G. Kaklamani and 53 more
- Charles M. PerouMay Goldman Shaw Distinguished Professor of Molecular Oncology, University of North Carolina at Chapel HillWilliam L. McGuire Memorial Lecture · 2026
- Fabrice AndréInstitut Gustave RoussyPrecision Medicine for Patients Living with Breast Cancer · 2026
- Virginia G. KaklamaniSymposium Co-director, UT Health San AntonioModerator · Opening remarks and Year in Review · 2026
- Carlos L. ArteagaSymposium Co-director, UT Southwestern Medical CenterModerator · Opening remarks and keynote address · 2026
- Aditya BardiaUniversity of California Los AngelesYear in Review, Early Breast Cancer · 2026
- Barbara PistilliGustave RoussyYear in Review, Advanced Breast Cancer · 2026
- Christos SotiriouInstitut Jules BordetYear in Review, Translational Science · 2026
- Qing ZhangUT Southwestern Medical CenterYear in Review, Basic Science · 2026
- Nadia HarbeckLMU University HospitalDebate. Trastuzumab Deruxtecan Before or After Surgery · 2026
- Sibylle LoiblGoethe University of FrankfurtDebate. Trastuzumab Deruxtecan Before or After Surgery · 2026
- William GradisharRobert H. Lurie Comprehensive Cancer Center of Northwestern UniversityModerator · Debate and ADC Controversies · 2026
- Peter SchmidQueen Mary University of LondonManagement of Toxicities Associated with ADCs · 2026
- Ana Christina Garrido-CastroDana-Farber Cancer InstituteSequencing and Biomarker Selection in the Use of ADCs · 2026
- Harold BursteinDana-Farber Cancer InstituteNeoadjuvant Endocrine Therapy · 2026
- Erika HamiltonSarah Cannon Research InstituteLessons from the First PROTAC Used in Cancer · 2026
- Rebecca DentNational University Hospital SingaporeControversies in Triple-Negative Breast Cancer · 2026
- Kevin KalinskyEmory Winship Cancer InstituteEndocrine-Based Treatment in HR+/HER2- MBC · 2026
- Timothy YapUniversity of Texas MD Anderson Cancer CenterNovel CDK Inhibitors · 2026
- Funda Meric-BernstamUT MD Anderson Cancer CenterModerator · Targeting the Epigenome in Breast Cancer · 2026
- Susan DomchekUniversity of PennsylvaniaBRCA Specific Vaccines · 2026
- George Thomas BuddCleveland ClinicAlpha Lactalbumin for TNBC Prevention · 2026
- Christina CurtisStanford UniversityMultiomic Architectures of Breast Tumors Across Populations · 2026
- Zhi-Ming ShaoFudan University Shanghai Cancer CenterAI-Driven Target Identification · 2026
- Amrita BasuUniversity of California San FranciscoModerator · Artificial Intelligence in Breast Cancer · 2026
- Siddhartha YadavMayo ClinicPolygenic Risk Score Implementation · 2026
- Seema A. KhanNorthwestern University Feinberg School of MedicineClinical Application of Risk Models · 2026
- Heather MooreDuke Cancer InstituteThe PI3K Balancing Act · 2026
- Gustavo WerutskyLACOG and Hospital Moinhos de VentoUnpacking ADCs · 2026
- Alexandra ThomasDuke UniversityModerator · New Therapies = New Toxicities · 2026
- Aleix PratClínic Barcelona Comprehensive Cancer CenterModerator · State of the Art 1. Treatment Optimization in Early Breast Cancer · 2026
- Gaia GriguoloUniversity of PadovaGenomic Profiling at Diagnosis · 2026
- Mitchell J. ElliottPrincess Margaret Cancer CentreLiquid Biopsy and Minimal Residual Disease · 2026
- Jo ChienUCSFctDNA Guided Endpoints in Metastatic Disease · 2026
- Anne Vincent SalomonInstitut CurieModerator · Workshop 2. AI Based Advances in Pathology · 2026
- Francisco Sanchez-VegaMemorial Sloan KetteringAI-Based Technology · 2026
- Sunil BadveEmory University School of MedicineModerator · Workshop 1. Beyond Animal Models · 2026
- Sarat ChandarlapatyMemorial Sloan Kettering Cancer CenterModerator · General Session 3 · 2026
- Christine DesmedtKU LeuvenObesity-associated Changes in Breast Cancer Biology, and moderator of Lobular Breast Cancer. Not a Rare Disease · 2026
- Mylin TorresEmory UniversityADCs and Radiotherapy in Breast Cancer · 2026
- Daniel HollernThe Salk Institute for Biological StudiesB Cells · 2026
- Justin M. BalkoVanderbilt University Medical CenterModerator · Organ-Specific Metastases and Systemic Immunity · 2026
- Senthil DamodaranMD Anderson Cancer CenterPanelist · Molecular Tumor Board · 2026
- Adrienne G. WaksDana-Farber Cancer InstitutePanelist · Molecular Tumor Board · 2026
- Mary L. (Nora) DisisProfessor, Division of Hematology and Oncology, University of Washington and Fred Hutch Cancer CenterModerator · Harnessing Immunity for Breast Cancer Prevention. Emerging Vaccines · 2026
- Olivera FinnDistinguished Professor, Departments of Immunology and Surgery, University of PittsburghHarnessing Immunity for Breast Cancer Prevention. Emerging Vaccines · 2026
- Carlos H. BarriosDirector, Oncology Research Center, Hospital São LucasModerator · A Global View of Breast Cancer. From Population Risk to Precision Care · 2026
- Valerie McCormackDeputy Head, Environment and Lifestyle Epidemiology Branch, International Agency for Research on CancerA Global View of Breast Cancer. From Population Risk to Precision Care · 2026
- Sarah (Sally) FriedewaldAcademic Division Chief of Breast Imaging, Mass General BrighamA Global View of Breast Cancer. From Population Risk to Precision Care · 2026
- Ava KwongDaniel C K Yu Professor in Breast Cancer Research, University of Hong KongA Global View of Breast Cancer. From Population Risk to Precision Care · 2026
- Tanja SpanicExecutive Director, Europa Donna SloveniaPanelist · A Global View of Breast Cancer. From Population Risk to Precision Care · 2026
- Fresia ParejaPathologist, Memorial Sloan Kettering Cancer CenterLobular Breast Cancer. Not a Rare Disease · 2026
- Caroline MalhaireRadiologist, Institut CurieLobular Breast Cancer. Not a Rare Disease · 2026
- Claire TurnerFounder, Lobular Breast Cancer UKPanelist · Lobular Breast Cancer. Not a Rare Disease · 2026
- Linnea I. ChapDirector of Breast Cancer and Women's Oncology, Beverly Hills Cancer CenterDaiichi Sankyo and AstraZeneca product theater on HER2+ breast cancer · 2026
- Michael F. PressProfessor of Pathology, Keck School of Medicine of USCDaiichi Sankyo and AstraZeneca product theater on HER2+ breast cancer · 2026
- Isaac Garcia-MurillasResearcher, The Institute of Cancer Research and The Royal Marsden HospitalBio-Rad product theater on ESR1 mutation detection · 2026
Charles M. Perou of the University of North Carolina receives the 2026 William L. McGuire Memorial Lecture Award. He's known for the PAM50 gene signature for breast cancer subtypes.
Fabrice André of Gustave Roussy gives a plenary on precision medicine. Aditya Bardia, Barbara Pistilli, Christos Sotiriou and Qing Zhang present the Year in Review.
Nadia Harbeck and Sibylle Loibl face off in a debate on trastuzumab deruxtecan before or after surgery. Many sessions also include a patient advocate on the panel.
Special sessions add more names. Mary L. (Nora) Disis of the University of Washington moderates a session on prevention vaccines with Susan Domchek, George Thomas Budd and Olivera Finn.
Carlos H. Barrios chairs a global view of breast cancer with Valerie McCormack of IARC, Christina Curtis and Ava Kwong. Christine Desmedt of KU Leuven leads the lobular breast cancer session with Fresia Pareja and Caroline Malhaire.
At the 2025 edition, award lectures came from Armando E. Giuliano, Ben Ho Park and Sara M. Tolaney. Many 2026 oral and poster slots come from submitted abstracts, and teams running their own calls can compare abstract management software.
Who spoke at SABCS San Antonio Breast Cancer Symposium 2025 (3)
- Armando E. Giuliano, Chief of breast surgical oncology, Cedars-Sinai Medical Center
- Ben Ho Park, Director, Vanderbilt-Ingram Cancer Center, Vanderbilt-Ingram Cancer Center
- Sara M. Tolaney, Chief, Division of Breast Oncology, Dana-Farber Cancer Institute
Dates, venue and getting there
SABCS 2026 runs Tuesday to Friday, December 8 to 11, 2026. Onsite registration opens December 7, per the key dates page.
The venue is the Henry B. González Convention Center at 900 E. Market Street in downtown San Antonio, per the organizer.
Housing runs through CMR, and the official booking deadline is November 30, 2026. Free shuttles run from designated hotels each morning and evening.
Abstract titles went online October 30, and the full abstract text follows on November 23, per the key dates. The SABCS app for iOS and Android is due November 30, the same day housing closes.
Future dates are set as December 7 to 10, 2027, and December 5 to 8, 2028. The 2029 and 2030 dates are also published.
SABCS 2026 tickets and registration
Registration is open to physicians, researchers, nurses, students and patient advocates through SABCS.org. Late rates now apply. In-person regular registration costs $1,065 from November 3 to December 11, as checked on 10 November 2026.
AACR members now pay $865. Students pay $165, and patient advocates pay $75.
Virtual registration is priced by World Bank income group. In high-income countries it's now $785.
Groups of 15 or more pay a flat $955 in person or $725 virtual. There are no daily or partial rates.
Credentialed journalists can apply for free press registration. AACR says press conferences run December 9, 10 and 11.
History of SABCS
SABCS started in 1978 as a local meeting for San Antonio oncologists, per the organizer's history. The first edition, in a motel near the airport, had no more than 50 attendees.
Founders Bill McGuire and Chuck Coltman later opened it to research abstracts. It moved to the Hyatt Regency, then the Marriott Rivercenter, and then the convention center.
A partnership with the American Association for Cancer Research helped turn it into a global meeting. The organizer calls 2026 the symposium's 49th year.
Resources for exhibitors, sponsors and attendees
These official pages cover registration, exhibiting, the program and travel.
- SABCS 2026 registration and feesPasses, prices and policies
- Exhibition and support opportunitiesBooth rates, deadlines and the application
- 2026 exhibitor prospectusAudience data, rules and exhibitor services
- 2026 support prospectusSponsorship and branding options
- Official 2026 exhibitor listSearchable directory
- Interactive floor planBooth locations in the exhibit hall
- 2026 programSessions by day with speakers
- Key datesDeadlines for abstracts, registration and housing
- Hotels and housingOfficial hotel booking and shuttles
- Satellite symposiaThe 2026 evening CME schedule
- Product theatersThe 2026 industry-sponsored talks in Hall 3
- Affiliate meetingsRules and fees for hosting events during SABCS
- Onsite servicesRegistration hours, child care and the app
- Media and press registrationPolicies for journalists
- SABCS Meeting NewsOfficial news and session previews